These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11406471)

  • 21. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide.
    Hayashi T; Esaki T; Muto E; Kano H; Asai Y; Thakur NK; Sumi D; Jayachandran M; Iguchi A
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):782-92. PubMed ID: 10712404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
    Martínez-González J; Alfón J; Berrozpe M; Badimon L
    Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice.
    Amin-Hanjani S; Stagliano NE; Yamada M; Huang PL; Liao JK; Moskowitz MA
    Stroke; 2001 Apr; 32(4):980-6. PubMed ID: 11283400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism.
    Hayashi T; Matsui-Hirai H; Fukatsu A; Sumi D; Kano-Hayashi H; Rani P JA; Iguchi A
    Atherosclerosis; 2006 Aug; 187(2):316-24. PubMed ID: 16325187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of NO synthase inhibitor failed to promote arteriosclerotic lesions in the aorta and the coronary arteries of rabbits fed cholesterol.
    Nakamura M; Abe S; Tanaka M
    Atherosclerosis; 1998 Nov; 141(1):53-60. PubMed ID: 9863538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine.
    Mozes G; Kullo IJ; Mohacsi TG; Cable DG; Spector DJ; Crotty TB; Gloviczki P; Katusic ZS; O'Brien T
    Atherosclerosis; 1998 Dec; 141(2):265-71. PubMed ID: 9862175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways.
    de Sotomayor MA; Pérez-Guerrero C; Herrrera MD; Jimenez L; Marín R; Marhuenda E; Andriantsitohaina R
    Br J Pharmacol; 2005 Dec; 146(8):1130-8. PubMed ID: 16231003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.
    Shah DI; Singh M
    Int J Cardiol; 2007 Sep; 120(3):317-24. PubMed ID: 17240464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin improves diabetes-induced coronary endothelial dysfunction.
    Tawfik HE; El-Remessy AB; Matragoon S; Ma G; Caldwell RB; Caldwell RW
    J Pharmacol Exp Ther; 2006 Oct; 319(1):386-95. PubMed ID: 16849625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia: the possible role of peroxynitrite (ONOO(-)).
    Hayashi T; Yamada K; Esaki T; Kano H; Asai Y; Kumar Thakur N; Jayachandran M; Sumi D; Iguchi A
    Atherosclerosis; 1999 Dec; 147(2):349-63. PubMed ID: 10559521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-atherosclerotic effect of beta-blocker with nitric oxide-releasing action on the severe atherosclerosis.
    Thakur NK; Hayashi T; Sumi D; Kano H; Matsui-Hirai H; Tsunekawa T; Iguchi A
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):298-309. PubMed ID: 11791016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene transfer of manganese superoxide dismutase reverses vascular dysfunction in the absence but not in the presence of atherosclerotic plaque.
    Zanetti M; Sato J; Jost CJ; Gloviczki P; Katusic ZS; O'Brien T
    Hum Gene Ther; 2001 Jul; 12(11):1407-16. PubMed ID: 11485632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation.
    Martínez-González J; Raposo B; Rodríguez C; Badimon L
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):804-9. PubMed ID: 11348878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of endothelial nitric oxide synthase expression in the vascular wall and in mononuclear cells from hypercholesterolemic rabbits.
    Jiménez A; Arriero MM; López-Blaya A; González-Fernandez F; García R; Fortes J; Millás I; Velasco S; Sánchez De Miguel L; Rico L; Farré J; Casado S; López-Farré A
    Circulation; 2001 Oct; 104(15):1822-30. PubMed ID: 11591621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS.
    Seker FB; Kilic U; Caglayan B; Ethemoglu MS; Caglayan AB; Ekimci N; Demirci S; Dogan A; Oztezcan S; Sahin F; Yilmaz B; Kilic E
    Neuroscience; 2015 Jan; 284():349-359. PubMed ID: 25453767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zn deficiency aggravates hypertension in spontaneously hypertensive rats: possible role of Cu/Zn-superoxide dismutase.
    Sato M; Yanagisawa H; Nojima Y; Tamura J; Wada O
    Clin Exp Hypertens; 2002 Jul; 24(5):355-70. PubMed ID: 12109776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway.
    Zhang Z; Wang M; Xue SJ; Liu DH; Tang YB
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):31-40. PubMed ID: 22083280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simvastatin acts synergistically with ACE inhibitors or amlodipine to decrease oxygen consumption in rat hearts.
    Mital S; Magneson A; Loke KE; Liao J; Forfia PR; Hintze TH
    J Cardiovasc Pharmacol; 2000 Aug; 36(2):248-54. PubMed ID: 10942168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits.
    Holm P; Andersen HL; Andersen MR; Erhardtsen E; Stender S
    Circulation; 1999 Oct; 100(16):1727-33. PubMed ID: 10525493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.